Safety, Pharmacokinetics, and Preliminary Efficacy of Isatuximab in Patients Awaiting Kidney Transplantation

NCT04294459 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

23

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated due to non-safety reasons

Conditions

Immune System Disorder

Interventions

DRUG: Isatuximab SAR650984
DRUG: Acetaminophen (paracetamol) or equivalent
DRUG: Ranitidine or equivalent
DRUG: Diphenhydramine or equivalent
DRUG: Methylprednisolone or equivalent
DRUG: Montelukast or equivalent

Sponsor

Sanofi